May 12, 2020 / 10:11 PM / 23 days ago

BRIEF-Genocea Introduces Gen-011, A Transformational T Cell Therapy Designed To Improve On Current Limitations Of Til Therapy

May 12 (Reuters) - Genocea Biosciences Inc:

* GENOCEA INTRODUCES GEN-011, A TRANSFORMATIONAL T CELL THERAPY DESIGNED TO IMPROVE ON CURRENT LIMITATIONS OF TIL THERAPY

* GENOCEA BIOSCIENCES INC - TO ADVANCE GEN-011, WITH AN IND FILING WITHIN Q2 AND INITIAL CLINICAL DATA IN FIRST HALF OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below